Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash from Investing Activities: 2013-2018

Historic Cash from Investing Activities for Armata Pharmaceuticals (ARMP) over the last 5 years, with Dec 2018 value amounting to -$535,000.

  • Armata Pharmaceuticals' Cash from Investing Activities fell 2872.22% to -$535,000 in Q4 2018 from the same period last year, while for Dec 2018 it was -$597,000, marking a year-over-year decrease of 929.31%. This contributed to the annual value of -$1.9 million for FY2024, which is 76.90% up from last year.
  • According to the latest figures from Q4 2018, Armata Pharmaceuticals' Cash from Investing Activities is -$535,000, which was down 4,763.64% from -$11,000 recorded in Q3 2018.
  • Armata Pharmaceuticals' 5-year Cash from Investing Activities high stood at -$2,000 for Q2 2017, and its period low was -$831,000 during Q2 2014.
  • Over the past 3 years, Armata Pharmaceuticals' median Cash from Investing Activities value was -$23,500 (recorded in 2016), while the average stood at -$88,300.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first spiked by 98.92% in 2015, then tumbled by 2,872.22% in 2018.
  • Armata Pharmaceuticals' Cash from Investing Activities (Quarterly) stood at -$5,000 in 2014, then slumped by 900.00% to -$50,000 in 2015, then surged by 74.00% to -$13,000 in 2016, then tumbled by 38.46% to -$18,000 in 2017, then slumped by 2,872.22% to -$535,000 in 2018.
  • Its Cash from Investing Activities was -$535,000 in Q4 2018, compared to -$11,000 in Q3 2018 and -$18,000 in Q4 2017.